Handa Pharmaceuticals, Inc. (6620.TWO)

TWD 51.5

(-2.83%)

Total Liabilities Summary of Handa Pharmaceuticals, Inc.

  • Handa Pharmaceuticals, Inc.'s latest annual total liabilities in 2023 was 280.88 Million TWD , up 304.48% from previous year.
  • Handa Pharmaceuticals, Inc.'s latest quarterly total liabilities in 2024 Q2 was 244.7 Million TWD , down -47.88% from previous quarter.
  • Handa Pharmaceuticals, Inc. reported annual total liabilities of 69.44 Million TWD in 2022, up 96.03% from previous year.
  • Handa Pharmaceuticals, Inc. reported annual total liabilities of 35.42 Million TWD in 2021, down -18.44% from previous year.
  • Handa Pharmaceuticals, Inc. reported quarterly total liabilities of 244.7 Million TWD for 2024 Q2, down -47.88% from previous quarter.
  • Handa Pharmaceuticals, Inc. reported quarterly total liabilities of 114.82 Million TWD for 2023 Q3, up 5.36% from previous quarter.

Annual Total Liabilities Chart of Handa Pharmaceuticals, Inc. (2023 - 2019)

Historical Annual Total Liabilities of Handa Pharmaceuticals, Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 280.88 Million TWD 304.48%
2022 69.44 Million TWD 96.03%
2021 35.42 Million TWD -18.44%
2020 43.43 Million TWD 0.0%
2019 - TWD 0.0%

Peer Total Liabilities Comparison of Handa Pharmaceuticals, Inc.

Name Total Liabilities Total Liabilities Difference
Allied Biotech Corporation 910.11 Million TWD 69.138%
GeneFerm Biotechnology Co., Ltd. 282.53 Million TWD 0.586%
Easywell Biomedicals, Inc. 589.98 Million TWD 52.392%
TTY Biopharm Company Limited 3.36 Billion TWD 91.662%
Synmosa Biopharma Corporation 3.62 Billion TWD 92.257%
Orient EuroPharma Co., Ltd. 6.64 Billion TWD 95.776%
Center Laboratories, Inc. 6.78 Billion TWD 95.861%
Tien Liang BioTech Co., Ltd. 161.05 Million TWD -74.404%
Orient Pharma Co., Ltd. 892.18 Million TWD 68.518%
InnoPharmax Inc. 48.64 Million TWD -477.362%
Johnson Chemical Pharmaceutical Works Co., Ltd. 320.99 Million TWD 12.496%
Excelsior Biopharma Inc. 472.87 Million TWD 40.601%
DV Biomed Co., Ltd. 765.87 Million TWD 63.325%
Foresee Pharmaceuticals Co., Ltd. 616.93 Million TWD 54.471%
UniPharma Co., Ltd. 37.4 Million TWD -650.999%
Anxo Pharmaceutical Co., Ltd. 1.01 Billion TWD 72.336%
Alar Pharmaceuticals Inc. 76.08 Million TWD -269.148%
Winston Medical Supply Co., Ltd. 373.87 Million TWD 24.873%
Mercury Biopharmaceutical Corporation 49.72 Million TWD -464.914%
Bioray Biotech Co., Ltd 108.75 Million TWD -158.277%
TSH Biopharm Corporation Limited 133.62 Million TWD -110.199%